| Literature DB >> 24282482 |
Rohit C Khanna1, Gudlavalleti V S Murthy, Pyda Giridhar, Sannapaneni Krishnaiah, Hira B Pant, Ghanshyam Palamaner Subash Shantha, Subhabrata Chakrabarti, Clare Gilbert, Gullapalli N Rao.
Abstract
BACKGROUND: A large-scale prevalence survey of blindness and visual impairment (The Andhra Pradesh Eye Diseases Study [APEDS1]) was conducted between 1996-2000 on 10,293 individuals of all ages in three rural and one urban clusters in Andhra Pradesh, Southern India. More than a decade later (June 2009-March 2010), APEDS1 participants in rural clusters were traced (termed APEDS2) to determine ocular risk factors for mortality in this longitudinal cohort. METHODS ANDEntities:
Mesh:
Year: 2013 PMID: 24282482 PMCID: PMC3837009 DOI: 10.1371/journal.pone.0078002
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Availability status of participants at the time of APEDS2.
Distribution of various demographic, lifestyle and systemic risk factors for mortality in APEDS2.
|
|
|
|
|
|---|---|---|---|
|
|
|
| |
|
| |||
| 30 - 39 | 1338 (39.5) | 60 (7.5) | 1398 (33.4) |
| 40 - 49 | 939 (27.7) | 90 (11.3) | 1029 (24.6) |
| 50 -59 | 632 (18.7) | 155 (19.4) | 787 (18.8) |
| 60 - 69 | 397 (11.7) | 319 (39.9) | 716 (17.1) |
| ≥ 70 | 83 (2.5) | 175 (21.9) | 258 (6.2) |
|
| |||
| Male | 1533 (45.2) | 431 (53.9) | 1964 (46.9) |
| Female | 1856 (54.8) | 368 (46.1) | 2224 (53.1) |
|
| |||
| Illiterate | 2130 (62.9) | 551 (69) | 2681 (64) |
| Class 1-5 | 707 (20.9) | 173 (21.7) | 880 (21.2) |
| Class 6-10 | 439 (13) | 57 (7.1) | 496 (11.8) |
| Class 11 and above | 113 (3.3) | 18 (2.3) | 131 (3.1) |
|
| |||
| Absent | 2230 (65.8) | 410 (51.3) | 2640 (63) |
| Present | 1159 (34.2) | 389 (48.7) | 1548 (37) |
|
| |||
| Absent | 3345 (98.8) | 763 (95.5) | 4108 (98.1) |
| Present | 42 (1.2) | 36 (4.5) | 78 (1.9) |
|
| |||
| Never smoker | 2817 (83.2) | 603 (75.5) | 3420 (81.7) |
| Former smoker | 280 (8.3) | 48 (6) | 328 (7.8) |
| Current smoker | 291 (8.6) | 148 (18.5) | 439 (10.5) |
|
| |||
| Normal | 1636 (49.7) | 295 (40.7) | 1931 (48.1) |
| Under weight | 1369 (41.6) | 360 (49.7) | 1729 (43.1) |
| Over weight | 236 (7.2) | 55 (7.6) | 291 (7.3) |
| Obese | 49 (1.5) | 15 (2.1) | 214 (1.6) |
|
| |||
| Never Drinker | 2254 (66.5) | 515 (64.5) | 2769 (66.1) |
| Former Drinker | 836 (24.7) | 221 (27.7) | 1057 (25.2) |
| Current Drinker | 298 (8.8) | 63 (7.9) | 361 (8.6) |
* Not significant association seen. Rest all association were significant at P<0.05 level
$ Cigarette, Chuta (Indigenous Cigar) and Beedies smoking
Distribution of cataract morphology and other ocular risk factors for mortality.
|
|
|
|
|
|---|---|---|---|
|
|
|
| |
|
| |||
| 6/6-6/18 | 2665 (78.7) | 326 (40.9) | 2991 (71.5) |
| <6/18-6/60 | 620 (18.3) | 367 (46) | 987 (23.6) |
| <6/60 | 101 (3) | 105 (13.2) | 206 (4.9) |
|
| |||
| Yes | 194 (5.7) | 160 (20) | 354 (8.5) |
| No | 3195 (94.3) | 639 (80) | 3834 (91.5) |
|
| |||
| Yes | 106 (3.1) | 43 (5.4) | 149 (3.6) |
| No | 3283 (96.9) | 756 (94.6) | 4039 (96.4) |
|
| |||
| Yes | 74 (2.2) | 27 (3.4) | 101 (2.4) |
| No | 3315 (97.8) | 772 (96.6) | 4087 (97.6) |
|
| |||
| Yes | 205 (6.1) | 201 (25.2) | 406 (9.7) |
| No | 3184 (94) | 598 (74.8) | 3782 (90.3) |
|
| |||
| Yes | 48 (1.4) | 49 (6.1) | 97 (2.3) |
| No | 3335 (98.6) | 749 (93.9) | 4084 (97.7) |
|
| |||
| Yes | 627 (18.5) | 480 (60.2) | 1104 (26.4) |
| No | 2756 (81.5) | 318 (39.8) | 3077 (73.6) |
|
| |||
| Present | 32 (0.9) | 22 (2.7) | 54 (1.3) |
| Absent | 3356 (99.1) | 777 (97.3) | 4133 (98.7) |
All association were significant at P<0.05 level; §ARMD: Age Related Macular Degeneration;
Univariable association of systemic disease, demographic and lifestyle factors with mortality.
|
|
| ||
|---|---|---|---|
|
|
|
| |
| Age group (yrs) | |||
| 30 - 39 | 1.00 | ||
| 40 - 49 | 2.08 | 1.49, 2.88 | |
| 50 - 59 | 4.94 | 3.66, 6.66 | |
| 60 - 69 | 13 | 9.84, 17.15 | |
| ≥ 70 | 24.82 | 18.46, 33.38 | |
|
| |||
| Male | 1.00 | ||
| Female | 0.73 | 0.63, 0.84 | |
|
| |||
| Illiterate | 1.00 | ||
| Class 1 - 5 | 0.97 | 0.82, 1.16 | |
| Class 6 - 10 | 0.56 | 0.43, 0.74 | |
| Class 11 and above | 0.74 | 0.47, 1.19 | |
|
| |||
| No | 1.00 | ||
| Yes | 3.08 | 2.21, 4.31 | |
|
| |||
| No | 1.00 | ||
| Yes | 1.7 | 1.48, 1.95 | |
|
| |||
| Normal | 1.00 | ||
| Underweight | 1.39 | 1.19, 1.62 | |
| Overweight | 1.26 | 0.95, 1.69 | |
| Obese | 1.51 | 0.88, 2.58 | |
|
| |||
| Never smoker | 1.00 | ||
| Former smoker | 1.80 | 1.37, 2.38 | |
| Heavy smoker | 1.42 | 1.18, 1.71 | |
* Cigarettes, Chuta (indigenous Cigar) and Beedies
Univariable association of ocular factors with subsequent mortality.
|
|
|
|
|
|---|---|---|---|
|
| |||
| ≥6/18 | 1.00 | ||
| <6/18 - 6/60 | 3.88 | 3.34, 4.51 | |
| <6/60 | 6.27 | 5.03, 7.82 | |
|
| |||
| No | 1.00 | ||
| Yes | 2.47 | 1.61, 3.77 | |
|
| |||
| No | 1.00 | ||
| Yes | 3.17 | 2.67, 3.77 | |
|
| |||
| No | 1.00 | ||
| Yes | 1.55 | 1.14, 2.11 | |
|
| |||
| No | 1.00 | ||
| Yes | 1.5 | 1.02, 2.2 | |
|
| |||
| No | 1.00 | ||
| Yes | 3.9 | 3.33, 4.58 | |
|
| |||
| No | 1.00 | ||
| Yes | 3.46 | 2.59, 4.64 | |
|
| |||
| No | 1.00 | ||
| Yes | 5.1 | 4.41, 5.86 |
§ ARMD: Age Related Macular Degeneration; * PSC: Posterior Subcapsular Cataract
Multivariable association of ocular factors with mortality in four different models.
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | ||
|
| |||||
| ≥6/18 | 1.00 (Ref) | ---- | 1.00 (Ref) | 1.00 (Ref) | |
| <6/18-6/60 | 1.42 (1.18, 1.69)* | ---- | 1.23 (1.01-1.48)* | 1.19 (0.9, 1.45) | |
| <6/60 | 1.89 (1.45, 2.47)* | ---- | 1.57 (1.19-2.07)* | 1.46 (1.1, 1.95)* | |
|
| 0.15 | ---- | ---- | ---- | |
|
| |||||
| No | ---- | ---- | 1.00 (Ref) | 1.00 (Ref) | |
| Yes | ---- | ---- | 1.26 (0.8-1.98) | 1.25 (0.79, 1.97) | |
|
| |||||
| No | ---- | 1.00 (Ref) | ---- | 1.00 (Ref) | |
| Yes | ---- | 1.8 (1.43, 2.27)* | ---- | 1.61 (1.25, 2.07)* | |
|
| |||||
| No | ---- | 1.00 (Ref) | ---- | 1.00 (Ref) | |
| Yes | ---- | 1.48 (1.05, 2.08)* | ---- | 1.49 (1.06, 2.09)* | |
|
| |||||
| No | ---- | 1.00 (Ref) | ---- | 1.00 (Ref) | |
| Yes | ---- | 1.00 (0.62, 1.58) | ---- | 0.97 (0.61, 1.54) | |
|
| |||||
| No | ---- | 1.00 (Ref) | ---- | 1.00 (Ref) | |
| Yes | ---- | 1.96 (1.57, 2.44)* | ---- | 1.75 (1.38, 2.23)* | |
|
| |||||
| No | ---- | 1.00 (Ref) | ---- | 1.00 (Ref) | |
| Yes | ---- | 2.01 (1.41, 2.88)* | ---- | 1.82 (1.26, 2.62)* | |
|
| ---- | 0.31 | ---- | 0.08 | |
|
| |||||
| No | ---- | ---- | 1.00 (Ref) | ---- | |
| Yes | ---- | ---- | 1.58 (1.30-1.92)* | ---- | |
|
| ---- | 0.31 | 0.12 | ---- |
$ Adjusted for age, gender, education level, diabetes, hypertension, BMI and smoking status.
§ ARMD: Age Related Macular Degeneration; * PSC: Posterior Subcapsular Cataract # goodness-of fit test; Ref: Reference group; * statistically significant (p<0.05)
Figure 2Survival curves for visual impairment and mortality: a) Unadjusted and b) Adjusted for age and gender.
Figure 3Survival curves for cataract morphology and mortality: a) Unadjusted and b) Adjusted for age and gender.
The incidence of mortality and duration of follow up duration across different studies.
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| 1 | Framingham Heart Study (1985)[ | 4.8-8 | 52-85 | 1945 | 312 (16) |
| 2 | The Beaver Dam Eye Study (1995)[ | 5 | 43-84 | 4926 | 467 (9.5) |
| 3 | Salisbury Eye Evaluation (1997)[ | 2 | 65-84 | 2520 | 147 (5.8) |
| 4 | Barbados Eye Study (2001)[ | 4 | 40-84 | 4709 | 306 (6.8) |
| 5 | Melbourne Visual Impairment Project (2001)[ | 5 | 40-98 | 3271 | 231 (7.1) |
| 6 | Blue Mountain Eye Study (2001)[ | 5 | >=49 | 3654 | 604 (16.5) |
| 7 | North London Eye Study (2002)[ | 4 | >65 | 1502 | 222 (14.7) |
| 8 | The Rotterdam Study (2003)[ | 7 | >=55 | 6339 | 1359 (21.4) |
| 9 | Priverno Eye Study (2004)[ | 7 | 45-69 | 860 | 44 (5.1) |
| 10 | Age Related Eye Disease Study (2004)[ | 9 | 55-81 | 4753 | 534 (11) |
| 11 | The Copenhagen City Eye Study (2005)[ | 14 | 60-80 | 964 | 577 (60.9) |
| 12 | The Beaver Dam Eye Study (2006)[ | 14 | 43-84 | 4926 | 1576 (32) |
| 13 | Blue Mountain Eye Study (2007)[ | 11 | >=49 | 3654 | 1039 (28.9) |
| 14 | Tanjong Pagar Study (2008)[ | 7 | >=40 | 1232 | 126 (10.2) |
| 15 | Beijing Eye Study (2008)[ | 5 | >=40 | 4439 | 143 (3.2) |
| 16 | Harbin Eye Study (2011)[ | 4 | 50-96 | 5057 | 214 (4.2) |
| 17 | APEDS2 (Present study) | 11 | >=30 | 4188 | 799 (19.1) |
The risk factors for mortality across different studies.
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
| 1 | Framingham Heart Study (1985)[ | NA | + in diabetics | + in diabetics | + in diabetics | NA | NA | NA | NA |
| 2 | The Beaver Dam Eye Study (1995)[ | - |
| - | - | NA | - | - | - |
| 3 | Salisbury Eye Evaluation (1997)[ | NA |
| - | - |
| NA | - | NA |
| 4 | Barbados Eye Study (2001)[ | NA |
| - | - |
| NA | NA | NA |
| 5 | Melbourne Visual Impairment Project (2001)[ |
| - |
| - | NA | NA | - | - |
| 6 | Blue Mountain Study (2001)[ |
|
|
|
| NA | NA | - | - |
| 7 | North London Eye Study (2002)[ | NA | + in non-diabetics women | + in non-diabetics women | + in non-diabetics women | NA | NA | NA | NA |
| 8 | The Rotterdam Study (2003)[ | NA | - | - | - | - | - | - | - |
| 9 | Priverno Eye Study (2004)[ | NA |
| - | - | - | NA |
| NA |
| 10 | Age Related Eye Disease Study (2004)[ |
|
| - | - | NA |
|
| + in advance ARMD |
| 11 | The Copenhagen City Eye Study (2005)[ | - | NA | NA | NA | NA | - | NA | + for women |
| 12 | The Beaver Dam Eye Study (2006)[ |
|
|
| - | NA |
| - | - |
| 13 | Blue Mountain Study (2007)[ | + for <75 years |
|
|
| NA |
| - | + for <75 years |
| 14 | Tanjong Pagar Study (2008)[ |
| - | - | - | NA | NA | - | NA |
| 15 | Beijing Eye Study (2008)[ | - | - | - | - | NA | NA | NA | NA |
| 16 | Harbin Eye Study (2011)[ |
| NA | NA | NA | NA | NA | NA | NA |
| 17 | APEDS2 (Present study) |
|
|
| - |
|
|
| - |
+ significant association; - Insignificant association; NA : Data not available